Nikko Asset Management Americas, Inc. Exact Sciences Corp Transaction History

Nikko Asset Management Americas, Inc.

$7.42 Billion
Q1 2025

A detailed history of Nikko Asset Management Americas, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 173,112 shares of EXAS stock, worth $8.39 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

173,112

Previous 541,180 68.01%

Holding current value

$8.39 Million

Previous $30.4 Million 75.36%

% of portfolio

0.1%

Previous 0.34%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	SELL	$43.04 - $58.51 $15.8 Million - $21.5 Million	-368,068 Reduced 68.01%	173,112 $7.49 Million
Q4 2024 Feb 10, 2025	SELL	$49.33 - $71.97 $6.77 Million - $9.88 Million	-137,288 Reduced 20.24%	541,180 $30.4 Million
Q3 2024 Nov 07, 2024	SELL	$42.43 - $70.83 $1.81 Million - $3.02 Million	-42,620 Reduced 5.91%	678,468 $46.2 Million
Q2 2024 Aug 09, 2024	SELL	$41.33 - $74.26 $33.3 Million - $59.9 Million	-806,838 Reduced 52.81%	721,088 $30.5 Million
Q1 2024 May 02, 2024	SELL	$56.27 - $73.77 $13 Million - $17 Million	-230,927 Reduced 13.13%	1,527,926 $106 Million
Q4 2023 Feb 08, 2024	SELL	$59.06 - $75.72 $12.1 Million - $15.5 Million	-204,394 Reduced 10.41%	1,758,853 $130 Million
Q3 2023 Nov 09, 2023	SELL	$65.94 - $99.04 $14.4 Million - $21.7 Million	-218,843 Reduced 10.03%	1,963,247 $134 Million
Q2 2023 Aug 14, 2023	SELL	$62.68 - $95.05 $69.1 Million - $105 Million	-1,101,885 Reduced 33.55%	2,182,090 $205 Million
Q1 2023 May 03, 2023	SELL	$47.19 - $70.77 $75.1 Million - $113 Million	-1,591,434 Reduced 32.64%	3,283,975 $223 Million
Q4 2022 Feb 13, 2023	SELL	$30.35 - $53.15 $35 Million - $61.3 Million	-1,153,211 Reduced 19.13%	4,875,409 $241 Million
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $22.6 Million - $35 Million	708,216 Added 13.31%	6,028,620 $197 Million
Q2 2022 Aug 04, 2022	BUY	$35.61 - $76.23 $5.55 Million - $11.9 Million	155,939 Added 3.02%	5,320,404 $200 Million
Q1 2022 May 06, 2022	SELL	$57.56 - $82.54 $14.6 Million - $21 Million	-254,335 Reduced 4.69%	5,164,465 $361 Million
Q4 2021 Feb 08, 2022	BUY	$72.5 - $100.68 $88.3 Million - $123 Million	1,218,384 Added 29.01%	5,418,800 $413 Million
Q3 2021 Nov 09, 2021	BUY	$90.24 - $124.05 $86.3 Million - $119 Million	955,854 Added 29.46%	4,200,416 $382 Million
Q2 2021 Aug 09, 2021	BUY	$93.66 - $139.27 $98 Million - $146 Million	1,046,432 Added 47.61%	3,244,562 $402 Million
Q1 2021 May 03, 2021	BUY	$116.57 - $155.01 $102 Million - $135 Million	872,841 Added 65.86%	2,198,130 $290 Million
Q4 2020 Feb 11, 2021	BUY	$99.61 - $142.12 $120 Million - $172 Million	1,209,150 Added 1041.12%	1,325,289 $176 Million
Q3 2020 Nov 02, 2020	BUY	$72.92 - $102.01 $8.47 Million - $11.8 Million	116,139 New	116,139 $11.9 Million

Others Institutions Holding EXAS

# of Institutions

644

Shares Held

157M

Call Options Held

1.83M

Put Options Held

1.56M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.58B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.

Account

Nikko Asset Management Americas, Inc. Exact Sciences Corp Transaction History